INTEGRATED BIOPHARMA INC (OTC:INBP) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 11, 2026.
The Consumer Defensive company reported Q0 revenue of .
INTEGRATED BIOPHARMA INC's stock currently trades at $0.29 with a market capitalization of $9.6M.